Application YC di Rosebud Biosciences

Winter 2022Active

Rosebud Biosciences ha partecipato a Y Combinator nel batch Winter 2022 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2022
Settore: HealthcareDrug Discovery and Delivery
Dimensione team: 3
Stato: Active
Lanciata: 2022

Founder

Kitch WilsonFounder
Evan LyallFounder

Cosa fa Rosebud Biosciences

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Application YC di Rosebud Biosciences, ricostruita

Domanda per Y Combinator

Rosebud Biosciences, batch Winter 2022. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rosebud Biosciences

Describe what your company does in 50 characters or less.

Growing micro-organs to find new drugs

What is your company going to make? Please describe your product and what it does or will do.

We grow organoids with the patients' exact gene mutations to test drugs directly on tissue models that behave like fetal organs. Our platform lets us screen drugs for rare diseases, especially pediatric conditions without treatments. It helps partners find drug candidates faster by using more accurate disease models than standard cell lines or animal models.

Where do you live now, and where would the company be based after YC?

We're based in San Francisco and San Carlos, CA. After YC, we'll stay in the Bay Area to stay close to collaborators and biotech talent.

Explain your decision regarding location.

We want to be near key research institutions and pharma partners, and both of us are already based in the Bay Area. It's where organoid research and biotech venture capital mix best.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Rosebud Biosciences?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Rosebud Biosciences (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Rosebud Biosciences si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Rosebud Biosciences?

Rosebud Biosciences apparteneva al batch Winter 2022 di Y Combinator.

Chi ha fondato Rosebud Biosciences?

Rosebud Biosciences è stato fondato da Kitch Wilson, Evan Lyall.

Cosa fa Rosebud Biosciences?

Growing micro-organs to find new drugs

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Rosebud Biosciences, e di ogni altro batch YC, è in YC Insights.